Variant report
| Variant | esv2762230 |
|---|---|
| Chromosome Location | chr1:241631807-241634520 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:2 , 50 per page) page:
1
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:48 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs58124241 | chr1:241633236-241633237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs565090729 | chr1:241633293-241633294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs377019728 | chr1:241633327-241633328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs2994978 | chr1:241633413-241633414 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 5 | rs544549722 | chr1:241633459-241633460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs575949070 | chr1:241633551-241633552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs543302460 | chr1:241633565-241633566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs538856655 | chr1:241633660-241633661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs528914976 | chr1:241633715-241633716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs2994979 | chr1:241633731-241633732 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 11 | rs565824357 | chr1:241633741-241633742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs554010407 | chr1:241633809-241633810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs117545913 | chr1:241633849-241633850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs114440446 | chr1:241633908-241633909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs572429011 | chr1:241633937-241633938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs557004928 | chr1:241633974-241633975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs186669533 | chr1:241633977-241633978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs564927491 | chr1:241634015-241634016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs536289390 | chr1:241634020-241634021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs144181593 | chr1:241634058-241634059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs191724687 | chr1:241634072-241634073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs545059259 | chr1:241634085-241634086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs183088848 | chr1:241634109-241634110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs140585728 | chr1:241634145-241634146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs114299839 | chr1:241634165-241634166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs186313043 | chr1:241634213-241634214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs530415521 | chr1:241634227-241634228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs191056618 | chr1:241634245-241634246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs559348642 | chr1:241634261-241634262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs116163073 | chr1:241634269-241634270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs2994980 | chr1:241634281-241634282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 32 | rs145366265 | chr1:241634299-241634300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs530654012 | chr1:241634300-241634301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs116747409 | chr1:241634301-241634302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs567497463 | chr1:241634308-241634309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs377640004 | chr1:241634343-241634344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs530689215 | chr1:241634354-241634355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs59580206 | chr1:241634361-241634362 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 39 | rs372810271 | chr1:241634364-241634365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs546598796 | chr1:241634381-241634382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs566495422 | chr1:241634382-241634383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs538626076 | chr1:241634402-241634403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs529850907 | chr1:241634415-241634416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs182292339 | chr1:241634426-241634427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs575682852 | chr1:241634450-241634451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs188034567 | chr1:241634492-241634493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs548036404 | chr1:241634498-241634499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs6696900 | chr1:241634520-241634521 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| Disease | PMID | Source |
|---|---|---|
| Esophageal squamous carcinoma | 21637470 | CNVD |
| HIV/AIDS | 22032296 | CNVD |
| Schizophrenia | 19415332 | CNVD |
| Melanoma | 18172304 | CNVD |
| Rett syndrome | 21593744 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Cancer | 20164919 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Non-small cell lung cancer | 21044232 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 20632083 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Gastrointestinal stromal cancer | 20470368 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Hepatocellular carcinoma | 22174799 | CNVD |
| Medulloblastoma | 21292688 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Multiple myeloma | 21628407 | CNVD |
| Cancer | 16751803 | CNVD |
| Prostate cancer | 16705090 | CNVD |
| Neuroblastoma | 19435921 | CNVD |
| Breast cancer | 17850661 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Intracranial tumor | 16823260 | CNVD |
| Medulloblastoma | 18056178 | CNVD |
| Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Neuroblastoma | 21899760 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Non-small cell lung cancer | 21385341 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Ewing''s sarcoma | 22429812 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Breast cancer | 17001317 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Testicular germ cell tumor | 18059402 | CNVD |
| Ependymoma | 18628472 | CNVD |
| Leukemia | 18628472 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Acute lymphoblastic leukemia | 19100363 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Chordoma | 18071362 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Hepatocellular carcinoma | 18803288 | CNVD |
| Urothelial tumor | 18831757 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Medulloblastoma | 16783165 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Congenital abnormalities | 21549014 | CNVD |
| Developmental delay | 21549014 | CNVD |
| Mental retardation | 21549014 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Cancer | 20164920 | CNVD |
| Cancer | 17060936 | CNVD |
| abnormal development | 18461090 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Acute lymphoblastic leukemia | 17443227 | CNVD |
| Myxofibrosarcoma | 16751306 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Arrhythmogenic right ventricular cardiomyopathy | 17576883 | CNVD |
| Multiple myeloma | 16616336 | CNVD |
| Developmental delay | 21147756 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Schizophrenia | 17989066 | CNVD |
| Breast cancer | 22522925 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr1:241633200-241634400 | Enhancers | Muscle Satellite Cultured Cells | -- |
| 2 | chr1:241633400-241634400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
| 3 | chr1:241633400-241635000 | Enhancers | Brain Germinal Matrix | brain |
| 4 | chr1:241633800-241634400 | Enhancers | Brain Inferior Temporal Lobe | brain |
| 5 | chr1:241633800-241634800 | Enhancers | NHLF | lung |
| 6 | chr1:241634200-241634400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
| 7 | chr1:241634200-241634400 | Enhancers | NHDF-Ad | bronchial |
| 8 | chr1:241634200-241635000 | Enhancers | Fetal Brain Male | brain |
| 9 | chr1:241634400-241638600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
| 10 | chr1:241634400-241639200 | Weak transcription | Brain Inferior Temporal Lobe | brain |





